Like sCD163, an increase in sCD206 from baseline to day 3–7 was significant in non-surviving ACLF patients compared with survivors, and high levels of sCD206 were present in patients with bacterial infection and sepsis as precipitating events [6]. This evidence concerns the gene CD163 and bacterial infectious disease.